Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q2 2021 Earnings Conference Call August 10, 2021 8:30 AM ET Company Participants John Jacobs - President & CEO Jeff Dierks - Chief Commercial Officer Jeff Dayno - Chief Medical Officer Sandip Kapadia - CFO Lisa Caperelli - IR Conference Call Participants Chris Howerton - Jefferies Graig Suvannavejh - Goldman Sachs David Amsellem - Piper Sandler Operator Good day, and thank you for standing by. Welcome to the Second Quarter 2021 Financial and Business Update C ...

Harmony Biosciences Q2 2021 Financial and Business Update August 10, 2021 Legal Disclaimer This presentation includes forward‐looking statements within the meaning of the Private Securities Reform Act of 1995. All statements other than statements of historical facts contained in these materials or elsewhere, including statements regarding Harmony Biosciences Holdings, Inc.'s (the "Company") future financial position, business strategy and plans and objectives of management for future operations, should be c ...

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2021 Earnings Conference Call May 11, 2021 8:30 AM ET Company Participants Lisa Caperelli - IR John Jacobs - President & CEO Jeff Dierks - Chief Commercial Officer Jeff Dayno - Chief Medical Officer Sandip Kapadia - CFO Conference Call Participants David Amsellem - Piper Sandler Chris Howerton - Jefferies Graig Suvannavejh - Goldman Sachs Operator Ladies and gentlemen, thank you for standing by. And welcome to the Harmony Biosciences First Quarter 2021 Fin ...

Harmony Biosciences Q1 2021 Financial and Business Update May 11, 2021 Legal Disclaimer This presentation includes forward‐looking statements within the meaning of the Private Securities Reform Act of 1995. All statements other than statements of historical facts contained in these materials or elsewhere, including statements regarding Harmony Biosciences Holdings, Inc.'s (the "Company") future financial position, business strategy and plans and objectives of management for future operations, should be cons ...